These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

225 related items for PubMed ID: 16805331

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Clinical implications of chemotherapy-induced diarrhea in patients with cancer.
    Arnold RJ, Gabrail N, Raut M, Kim R, Sung JC, Zhou Y.
    J Support Oncol; 2005; 3(3):227-32. PubMed ID: 15915825
    [Abstract] [Full Text] [Related]

  • 23. Quality-of-life and health benefits of early treatment of mild anemia: a randomized trial of epoetin alfa in patients receiving chemotherapy for hematologic malignancies.
    Straus DJ, Testa MA, Sarokhan BJ, Czuczman MS, Tulpule A, Turner RR, Riggs SA.
    Cancer; 2006 Oct 15; 107(8):1909-17. PubMed ID: 16977654
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Terlipressin vs. octreotide in bleeding esophageal varices as an adjuvant therapy with endoscopic band ligation: a randomized double-blind placebo-controlled trial.
    Abid S, Jafri W, Hamid S, Salih M, Azam Z, Mumtaz K, Shah HA, Abbas Z.
    Am J Gastroenterol; 2009 Mar 15; 104(3):617-23. PubMed ID: 19223890
    [Abstract] [Full Text] [Related]

  • 26. Control of irinotecan-induced diarrhea by octreotide after loperamide failure.
    Barbounis V, Koumakis G, Vassilomanolakis M, Demiri M, Efremidis AP.
    Support Care Cancer; 2001 Jun 15; 9(4):258-60. PubMed ID: 11430421
    [Abstract] [Full Text] [Related]

  • 27. Chemotherapy induced diarrhea.
    Richardson G, Dobish R.
    J Oncol Pharm Pract; 2007 Dec 15; 13(4):181-98. PubMed ID: 18045778
    [Abstract] [Full Text] [Related]

  • 28. An open trial of octreotide long-acting release in the management of short bowel syndrome.
    Nehra V, Camilleri M, Burton D, Oenning L, Kelly DG.
    Am J Gastroenterol; 2001 May 15; 96(5):1494-8. PubMed ID: 11374688
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Randomized trial of loperamide versus dose escalation of octreotide acetate for chemotherapy-induced diarrhea in bone marrow transplant and leukemia patients.
    Geller RB, Gilmore CE, Dix SP, Lin LS, Topping DL, Davidson TG, Holland HK, Wingard JR.
    Am J Hematol; 1995 Nov 15; 50(3):167-72. PubMed ID: 7485077
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Randomized, open-label comparison of epoetin alfa extended dosing (80 000 U Q2W) vs weekly dosing (40 000 U QW) in patients with chemotherapy-induced anemia.
    Henry DH, Gordan LN, Charu V, Wilhelm FE, Williams D, Xie J, Woodman RC.
    Curr Med Res Opin; 2006 Jul 15; 22(7):1403-13. PubMed ID: 16834839
    [Abstract] [Full Text] [Related]

  • 34. Clinical efficacy and safety of octreotide (SMS201-995) in terminally ill Japanese cancer patients with malignant bowel obstruction.
    Shima Y, Ohtsu A, Shirao K, Sasaki Y.
    Jpn J Clin Oncol; 2008 May 15; 38(5):354-9. PubMed ID: 18490369
    [Abstract] [Full Text] [Related]

  • 35. A 3-month course of long-acting repeatable octreotide (sandostatin LAR) improves portal hypertension in patients with cirrhosis: a randomized controlled study.
    Spahr L, Giostra E, Frossard JL, Morard I, Mentha G, Hadengue A.
    Am J Gastroenterol; 2007 Jul 15; 102(7):1397-405. PubMed ID: 17488248
    [Abstract] [Full Text] [Related]

  • 36. Octreotide Acetate in the Treatment of Fluorouracil-Induced Diarrhea.
    Goumas P, Naxakis S, Christopoulou A, Chrysanthopoulos C, Nikolopoulou V, Kalofonos HP.
    Oncologist; 1998 Jul 15; 3(1):50-53. PubMed ID: 10388084
    [Abstract] [Full Text] [Related]

  • 37. Understanding and managing chemotherapy-induced diarrhea.
    Saltz LB.
    J Support Oncol; 2003 Jul 15; 1(1):35-46; discussion 38-41, 45-6. PubMed ID: 15352641
    [Abstract] [Full Text] [Related]

  • 38. Octreotide therapy in dumping syndrome: Analysis of long-term results.
    Didden P, Penning C, Masclee AA.
    Aliment Pharmacol Ther; 2006 Nov 01; 24(9):1367-75. PubMed ID: 17059518
    [Abstract] [Full Text] [Related]

  • 39. Efficacy of octreotide in controlling refractory diarrhea following bone marrow transplantation.
    Morton AJ, Durrant ST.
    Clin Transplant; 1995 Jun 01; 9(3 Pt 1):205-8. PubMed ID: 7549062
    [Abstract] [Full Text] [Related]

  • 40. Octreotide alone or in combination with rofecoxib as palliative treatment for advanced hepatocellular cancer.
    Treiber G, Röcken C, Wex T, Malfertheiner P.
    Z Gastroenterol; 2007 May 01; 45(5):369-77. PubMed ID: 17503315
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.